BioCentury
ARTICLE | Company News

Elan sells Myobloc to Solstice

July 7, 2004 7:00 AM UTC

ELN sold the worldwide rights for Myobloc/ Neurobloc to Solstice Neurosciences. Myobloc is an injectable solution of botulinum toxin Type B approved in the U.S., Canada and Europe to treat cervical dy...